Collaboration Details

Print  Close


Title of Collaborative Activity:

Assessing Safety of Cell Substrates and Vaccine Components

Description of Collaborative Activity:

Production of many new vaccines requires the use of novel cell substrates. It is critical that these new cell substrates be well characterized and undergo rigorous safety testing prior to their use in manufacturing vaccines for human use. This IAA will examine the potential infectivity acquired by various cell lines after exposure to prions.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2014

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA